Sherita Ceasar

Aurion Biotech Expands Its Leadership Team

Retrieved on: 
Wednesday, November 30, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221130005132/en/
    Im delighted to welcome Sherita and Sterling to Aurion Biotech, said Greg Kunst, Aurion Biotech chief executive officer.
  • Before joining Aurion Biotech, Mr. Chung held regulatory leadership roles at Neoleukin Therapeutics, Molecular Templates, Immatics US, Seattle Genetics, Gilead Sciences, Astellas Pharmaceuticals, Takeda Pharmaceuticals, and Abbott Laboratories.
  • With offices in Seattle, Boston and Tokyo, Aurion Biotech is a clinical-stage biotech company, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies.
  • Aurion Biotech is the recipient of the prestigious Prix Galien award for best start-up in biotech.